110 related articles for article (PubMed ID: 7788259)
1. Is there a role for in vivo methylene blue staining in the prediction of bladder tumour recurrence?
Creagh TA; Gleeson M; Travis D; Grainger R; McDermott TE; Butler MR
Br J Urol; 1995 Apr; 75(4):477-9. PubMed ID: 7788259
[TBL] [Abstract][Full Text] [Related]
2. [Staining test with methylene blue during resection of bladder cancer in 30 patients].
Jia WY; Li WL; Chen HG
Zhonghua Wai Ke Za Zhi; 1994 Jun; 32(6):351-3. PubMed ID: 7531137
[TBL] [Abstract][Full Text] [Related]
3. Selective surface staining of bladder tumors by intravesical methylene blue with enhanced endoscopic identification.
Gill WB; Huffman JL; Lyon ES; Bagley DH; Schoenberg HW; Straus FH
Cancer; 1984 Jun; 53(12):2724-7. PubMed ID: 6202385
[TBL] [Abstract][Full Text] [Related]
4. Value of in vivo mucosa-staining test with methylene blue in the diagnosis of pretumoral and tumoral lesions of the bladder.
Vicente J; Chéchile G; Algaba F
Eur Urol; 1987; 13(1-2):15-6. PubMed ID: 2438139
[TBL] [Abstract][Full Text] [Related]
5. The Nd:YAG laser and methylene blue staining in the diagnosis and treatment of premalignant vesical lesions and carcinoma in situ (CIS).
Gaboardi F; Bordinazzo R; Galli L
Int Urol Nephrol; 1989; 21(3):289-97. PubMed ID: 2807780
[TBL] [Abstract][Full Text] [Related]
6. In vivo staining test with methylene blue for bladder cancer.
Fukui I; Yokokawa M; Mitani G; Ohwada F; Wakui M; Washizuka M; Tohma T; Igarashi K; Yamada T
J Urol; 1983 Aug; 130(2):252-5. PubMed ID: 6192250
[TBL] [Abstract][Full Text] [Related]
7. [Studies on multiple mucosal biopsy in patients with bladder cancer. 1. Evaluation of the results of multiple mucosal biopsy in patients with bladder cancer and in vivo methylene blue staining].
Igawa M
Hinyokika Kiyo; 1986 Nov; 32(11):1617-31. PubMed ID: 2435127
[TBL] [Abstract][Full Text] [Related]
8. The significance of urothelial dysplasia as diagnosed by cup biopsies.
Harewood LM
Aust N Z J Surg; 1986 Mar; 56(3):199-203. PubMed ID: 3459428
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis of clinically occult bladder cancer by in vivo staining with methylene blue.
Mufti GR; Shah PJ; Parkinson MC; Riddle PR
Br J Urol; 1990 Feb; 65(2):173-5. PubMed ID: 1690584
[TBL] [Abstract][Full Text] [Related]
10. Prognostic factors in pTa-pT1 superficial bladder tumours treated with intravesical instillations. The Dutch South-Eastern Urological Collaborative Group.
Mulders PF; Meyden AP; Doesburg WH; Oosterhof GO; Debruyne FM
Br J Urol; 1994 Apr; 73(4):403-8. PubMed ID: 8199828
[TBL] [Abstract][Full Text] [Related]
11. [Chromocystoscopy using methylene blue in the early diagnosis of tumors of the bladder and of precancerous lesions].
Galli L; Gaboardi F
Arch Esp Urol; 1985; 38(4):347-51. PubMed ID: 2416276
[No Abstract] [Full Text] [Related]
12. Comparison of methylene blue-directed biopsies and four-quadrant biopsies in the detection of high-grade intraepithelial neoplasia and early cancer in Barrett's oesophagus.
Gossner L; Pech O; May A; Vieth M; Stolte M; Ell C
Dig Liver Dis; 2006 Oct; 38(10):724-9. PubMed ID: 16911879
[TBL] [Abstract][Full Text] [Related]
13. Accuracy of magnifying endoscopy with methylene blue in the diagnosis of specialized intestinal metaplasia and short-segment Barrett's esophagus in Japanese patients without Helicobacter pylori infection.
Yagi K; Nakamura A; Sekine A
Gastrointest Endosc; 2003 Aug; 58(2):189-95. PubMed ID: 12872084
[TBL] [Abstract][Full Text] [Related]
14. Fluorescence diagnosis of bladder cancer.
Chatterton K; Ray E; O'Brien TS
Br J Nurs; 2006 Jun 8-21; 15(11):595-7. PubMed ID: 16835527
[TBL] [Abstract][Full Text] [Related]
15. Feasibility of photodynamic diagnosis for challenging TUR- Bt cases including muscle invasive bladder cancer, BCG failure or 2nd-TUR.
Takai T; Inamoto T; Komura K; Yoshikawa Y; Uchimoto T; Saito K; Tanda N; Kouno J; Minami K; Uehara H; Takahara K; Hirano H; Nomi H; Kiyama S; Azuma H
Asian Pac J Cancer Prev; 2015; 16(6):2297-301. PubMed ID: 25824753
[TBL] [Abstract][Full Text] [Related]
16. Outpatient diagnostic of bladder tumours in flexible cystoscopes: evaluation of fluorescence-guided flexible cystoscopy and bladder biopsies.
Hermann GG; Mogensen K; Toft BG; Glenthøj A; Pedersen HM
Scand J Urol Nephrol; 2012 Feb; 46(1):31-6. PubMed ID: 22150596
[TBL] [Abstract][Full Text] [Related]
17. Urinary bladder cancer test: a new urinary tumor marker in the follow-up of superficial bladder cancer.
Mungan NA; Vriesema JL; Thomas CM; Kiemeney LA; Witjes JA
Urology; 2000 Nov; 56(5):787-92. PubMed ID: 11068302
[TBL] [Abstract][Full Text] [Related]
18. The expression of thymidine phosphorylase is a prognostic predictor for the intravesical recurrence of superficial bladder cancer.
Nonomura N; Nakai Y; Nakayama M; Inoue H; Nishimura K; Hatanaka E; Arima R; Kishimoto T; Miki T; Kuroda H; Okuyama A
Int J Clin Oncol; 2006 Aug; 11(4):297-302. PubMed ID: 16937303
[TBL] [Abstract][Full Text] [Related]
19. Assessing treatment response after induction Bacillus Calmette-Guerin for carcinoma in situ of the urinary bladder: can post-induction random bladder biopsies be avoided?
Smith PJ; Lotan Y; Raj GV; Sagalowsky AI; Margulis V
Cytopathology; 2014 Apr; 25(2):108-11. PubMed ID: 23551700
[TBL] [Abstract][Full Text] [Related]
20. A randomized, prospective cross-over trial comparing methylene blue-directed biopsy and conventional random biopsy for detecting intestinal metaplasia and dysplasia in Barrett's esophagus.
Ragunath K; Krasner N; Raman VS; Haqqani MT; Cheung WY
Endoscopy; 2003 Dec; 35(12):998-1003. PubMed ID: 14648410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
